Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)

References
1 Berkun Y, Haviv YS, Schwartz LB. et al. Heparininduced recurrent anaphylaxis.. Clin Exp Allergy 2004; 34: 1916-8.
2 Kim J, Smith KJ, Toner C. et al. Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy.. Int J Dermatol 2004; 43: 252-60.
3 Koch P, Münßinger T, Rupp-John C. et al. Delayed type hypersensitivity skin reactions caused by subcutaneous unfractioned and low-molecular weight heparins. Tolerance of a new recombinant hirudin.. J Am Acad Dermatol 2000; 42: 612-9.
4 Jappe U, Juschka U, Kuner N. et al. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semi synthetic heparinoids? A study of 7 cases.. Contact Dermatitis 2004; 51: 67-72.
5 Koch P. Delayed-type hypersensitivity skin reaction due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.. Contact Dermatitis 2004; 49: 276-80.
6 Hallai N, Hughes M, Stone N. Type I and Type IV allergy to unfractionated heparin and low-molecularweight heparin with no reaction to recombinant hirudin.. Contact Dermatitis 2004; 51: 153-4.
7 Caballero MR, Fernández-Benitez M. Allergy to heparin: A new in vitro diagnostic technique.. Allergol et Immunopathol 2003; 31: 324-8.
8 Koch P, Reinhold S, Busch C. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.. Contact Dermatitis 2000; 42: 278-9.
9 Hohenstein E, Tsakiris D, Bircher AJ. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux.. Contact Dermatitis 2004; 51: 149-50.
10 Savas MC, Benekli M, Akcav A. et al. Heparin-associated refractory bronchospasm.. Ann Pharmacother 1997; 31: 253.
11 Coon WW, Willis PW. 3rd. Some side effects of heparin, heparinoids, and their antagonists.. Clin Pharmacol Ther 1966; 7: 379-98.
12 Ludwig RJ, Beier C, Lindhoff-Last E. et al. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.. Contact Dermatitis 2003; 49: 158-9.